Showing results (251-260 of 588) with videos related to
Sort By:
Pageof 59
Molecular Cancer Research : MCR|September 4, 2014
RNA-seq reveals aurora kinase-driven mTOR pathway activation in patients with sarcomatoid metastatic renal cell carcinomaSumanta K Pal, Miaoling He, Tommy Tong, et al.European Urology|April 18, 2017
Evolution of Circulating Tumor DNA Profile from First-line to Subsequent Therapy in Metastatic Renal Cell CarcinomaSumanta K Pal, Guru Sonpavde, Neeraj Agarwal, et al.Clinical Genitourinary Cancer|May 15, 2018
Comprehensive Genomic Profiling of Metastatic Tumors in a Phase 2 Biomarker Study of Everolimus in Advanced Renal Cell CarcinomaXin Gao, Opeyemi Jegede, Connor Gray, et al.European Urology|June 26, 2012
BRAF mutations in metanephric adenoma of the kidneyToni K Choueiri, John Cheville, Emanuele Palescandolo, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 2009
Interaction of molecular markers and physical activity on mortality in patients with colon cancerJeffrey A Meyerhardt, Shuji Ogino, Gregory J Kirkner, et al.Cancers|September 23, 2022
Circulating Cell-Free DNA in Renal Cell Carcinoma: The New Era of Precision MedicineEdoardo Francini, Giuseppe Nicolò Fanelli, Filippo Pederzoli, et al.Journal of the Academy of Nutrition and Dietetics|July 6, 2024
Coffee, Phosphoinositide 3-Kinase Signaling Pathway, and Prostate Cancer: A Prospective Study in the Health Professionals Follow-Up StudyRui Song, Konrad H Stopsack, Junkun Ren, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 13, 2017
Expression of PD-L1 in Hormone-naïve and Treated Prostate Cancer Patients Receiving Neoadjuvant Abiraterone Acetate plus Prednisone and LeuprolideCarla Calagua, Joshua Russo, Yue Sun, et al.Cancer Research|October 18, 2014
AKT1 and MYC induce distinctive metabolic fingerprints in human prostate cancerCarmen Priolo, Saumyadipta Pyne, Joshua Rose, et al.Cancer Biology & Therapy|September 6, 2007
Caveolin-1 is required for the upregulation of fatty acid synthase (FASN), a tumor promoter, during prostate cancer progressionDolores Di Vizio, Federica Sotgia, Terence M Williams, et al.Pageof 59